<SEC-DOCUMENT>0001193125-23-126993-index.html : 20230428
<SEC-HEADER>0001193125-23-126993.hdr.sgml : 20230428
<ACCEPTANCE-DATETIME>20230428161610
ACCESSION NUMBER:		0001193125-23-126993
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230428
DATE AS OF CHANGE:		20230428
EFFECTIVENESS DATE:		20230428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fulcrum Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001680581
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				474839948
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38978
		FILM NUMBER:		23866451

	BUSINESS ADDRESS:	
		STREET 1:		26 LANDSDOWNE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-651-8851

	MAIL ADDRESS:	
		STREET 1:		26 LANDSDOWNE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>d420054dars.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: d420054dars.pdf

</DOCUMENT>
</SEC-DOCUMENT>